RESPONSE TO MESNA, DOXORUBICIN, IFOSFAMIDE, AND DACARBAZINE IN 108 PATIENTS WITH METASTATIC OR UNRESECTABLE SARCOMA AND NO PRIOR CHEMOTHERAPY

被引：242

作者：

ELIAS, A

RYAN, L

SULKES, A

COLLINS, J

AISNER, J

ANTMAN, KH

机构：

[1] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV BIOSTAT,BOSTON,MA 02115

[2] UNIV MARYLAND,CTR CANC,DEPT ONCOL,BALTIMORE,MD 21201

[3] NCI,CLIN PHARMACOL BRANCH,BETHESDA,MD 20205

来源：

关键词：

D O I：

10.1200/JCO.1989.7.9.1208

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1208 / 1216

页数：9

共 56 条

[1] ALLEN LM, 1975, CLIN PHARMACOL THER, V17, P492
[2] ANTMAN K, 1989, CANCER PRINCIPLES PR, P1345
[3] RESPONSE TO IFOSFAMIDE AND MESNA - 124 PREVIOUSLY TREATED PATIENTS WITH METASTATIC OR UNRESECTABLE SARCOMA
ANTMAN, KH
RYAN, L
ELIAS, A
SHERMAN, D
GRIER, HE
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (01) : 126 - 131
[4] CHEMOTHERAPY OF ADVANCED SOFT-TISSUE SARCOMAS
ANTMAN, KH
ELIAS, AD
[J]. SEMINARS IN SURGICAL ONCOLOGY, 1988, 4 (01): : 53 - 58
[5] ANTMAN KH, 1985, CANCER TREAT REP, V69, P499
[6] BAKER L, 1987, P AN M AM SOC CLIN, V6, P138
[7] COMBINATION CHEMOTHERAPY USING ADRIAMYCIN, DTIC, CYCLOPHOSPHAMIDE, AND ACTINOMYCIN-D FOR ADVANCED SOFT-TISSUE SARCOMAS - A RANDOMIZED COMPARATIVE TRIAL - A PHASE-III, SOUTHWEST-ONCOLOGY-GROUP-STUDY (7613)
BAKER, LH
FRANK, J
FINE, G
BALCERZAK, SP
STEPHENS, RL
STUCKEY, WJ
RIVKIN, S
SAIKI, J
WARD, JH
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (06) : 851 - 861
[8] GRADE-3 NAUSEA, VOMITING, AND MYELOSUPPRESSION OR PROGRESSIVE, METASTATIC SARCOMA
BENJAMIN, RS
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (06) : 833 - 835
[9] CHEMOTHERAPY IN ADVANCED SARCOMAS
BIERBAUM, W
BREMER, K
FIRUSIAN, N
HIGI, M
NIEDERLE, N
SCHEULEN, ME
SCHMIDT, CG
SEEBER, S
[J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1981, 106 (37) : 1181 - &
[10] BODEY GP, 1981, CANCER, V47, P2422, DOI 10.1002/1097-0142(19810515)47:10<2422::AID-CNCR2820471017>3.0.CO